SZSE:300026 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SZSE:300026 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Tianjin Chase Sun Pharmaceutical Co's Other Stockholders Equity for the quarter that ended in Sep. 2024 was ¥876 Mil.
Tianjin Chase Sun Pharmaceutical Co's quarterly Other Stockholders Equity declined from Mar. 2024 (¥877 Mil) to Jun. 2024 (¥288 Mil) but then increased from Jun. 2024 (¥288 Mil) to Sep. 2024 (¥876 Mil).
Tianjin Chase Sun Pharmaceutical Co's annual Other Stockholders Equity increased from Dec. 2021 (¥228 Mil) to Dec. 2022 (¥263 Mil) and increased from Dec. 2022 (¥263 Mil) to Dec. 2023 (¥287 Mil).
The historical data trend for Tianjin Chase Sun Pharmaceutical Co's Other Stockholders Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin Chase Sun Pharmaceutical Co Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Other Stockholders Equity | Get a 7-Day Free Trial | 108.98 | 157.96 | 227.86 | 263.11 | 287.46 |
Tianjin Chase Sun Pharmaceutical Co Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Other Stockholders Equity | Get a 7-Day Free Trial | 858.21 | 287.46 | 876.70 | 288.28 | 875.62 |
Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity
Thank you for viewing the detailed overview of Tianjin Chase Sun Pharmaceutical Co's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Yao Xiao Qing | Director | |
Chen Rui Qiang | Executives | |
Li Chun Xu | Executives | |
Lan Wu Jun | Directors, Directors, and Executives | |
Zheng Dan | Directors, executives | |
Zhang Kun | Executives | |
Gao Guo Wei | Executives | |
Shang Xiao Mei | Securities Affairs Representative | |
Sun Zhang Hai | Director | |
Wu Guang Ning | Supervisors | |
Wang Long | Executives | |
Liu Qiang | Supervisors | |
Ceng Guo Zhuang | Director | |
Su Bing Jun | Directors, executives | |
Nie Wei | Supervisors |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.